Anixa Biosciences Inc (ANIX)

Dec 4, 2024, 8:30 AM EST - 6 weeks ago

Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10

Nov 22, 2024, 8:15 AM EST - 2 months ago

Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset

Nov 18, 2024, 8:20 AM EST - 2 months ago

Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial

Nov 8, 2024, 1:17 PM EST - 2 months ago

Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

Nov 6, 2024, 8:30 AM EST - 2 months ago

Anixa Biosciences Announces Timing of Public Release of Data from the Phase 1 Study of its Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

Oct 31, 2024, 8:15 AM EDT - 2 months ago

Anixa Biosciences to Present at the Sidoti Micro-Cap Virtual Conference on November 13 & 14, 2024

Oct 28, 2024, 8:30 AM EDT - 2 months ago

Anixa Biosciences and Cleveland Clinic to Present Additional Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

Oct 15, 2024, 9:00 AM EDT - 3 months ago

Anixa Biosciences Announces Second Dose Administered to Patient in Ovarian Cancer CAR-T Clinical Trial

Oct 7, 2024, 8:30 AM EDT - 3 months ago

Anixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical Development

Sep 30, 2024, 8:30 AM EDT - 3 months ago

Anixa Biosciences Announces Submission of Protocol Amendment for CAR-T Trial

Sep 24, 2024, 8:30 AM EDT - 4 months ago

Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine

Sep 18, 2024, 8:30 AM EDT - 4 months ago

Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Ovarian Cancer Research Alliance's International Gynecologic Cancer Conference

Sep 3, 2024, 8:30 AM EDT - 4 months ago

Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium

Aug 26, 2024, 8:30 AM EDT - 5 months ago

Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Jul 29, 2024, 8:45 AM EDT - 6 months ago

Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting

Jul 23, 2024, 8:15 AM EDT - 6 months ago

Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy

Jul 17, 2024, 8:00 AM EDT - 6 months ago

Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology

Jul 15, 2024, 8:30 AM EDT - 6 months ago

Anixa Biosciences Announces $5 Million Share Repurchase Program

Jun 24, 2024, 8:45 AM EDT - 7 months ago

Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial

May 21, 2024, 7:30 AM EDT - 8 months ago

Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial

May 8, 2024, 8:25 AM EDT - 9 months ago

Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines

May 6, 2024, 8:05 AM EDT - 9 months ago

Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay Juneja

Apr 30, 2024, 7:45 AM EDT - 9 months ago

Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024

Apr 18, 2024, 8:20 AM EDT - 9 months ago

Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board

Mar 14, 2024, 8:45 AM EDT - 11 months ago

Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties

Mar 11, 2024, 8:00 AM EDT - 11 months ago

Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress

Feb 12, 2024, 7:30 AM EST - 1 year ago

Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial

Jan 29, 2024, 8:50 AM EST - 1 year ago

Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference

Jan 23, 2024, 7:55 AM EST - 1 year ago

Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology

Jan 10, 2024, 9:00 AM EST - 1 year ago

Anixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024

Dec 14, 2023, 7:15 AM EST - 1 year ago

Anixa Biosciences to Present at Biotech Showcase 2024

Dec 6, 2023, 6:00 PM EST - 1 year ago

Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine

Dec 6, 2023, 4:05 PM EST - 1 year ago

Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine

Nov 27, 2023, 8:30 AM EST - 1 year ago

Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology

Oct 31, 2023, 8:30 AM EDT - 1 year ago

Anixa Biosciences to Present at the Ovarian Cancer Research Alliance (OCRA) Ovarian Cancer National Conference

Oct 23, 2023, 8:30 AM EDT - 1 year ago

Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board

Oct 13, 2023, 8:30 AM EDT - 1 year ago

Anixa Biosciences Completes Treatment of First Patient Cohort in Ovarian Cancer CAR-T Clinical Trial

Oct 3, 2023, 8:30 AM EDT - 1 year ago

Anixa Biosciences Announces Issuance of Additional U.S. Patent for Ovarian Cancer Vaccine Technology

Sep 19, 2023, 8:30 AM EDT - 1 year ago

Anixa Biosciences Establishes Cancer Business Advisory Board

Aug 31, 2023, 8:30 AM EDT - 1 year ago

Anixa Biosciences to Participate in September Investor Conferences

Aug 28, 2023, 8:30 AM EDT - 1 year ago

Anixa Biosciences Announces Treatment of Third Patient in Ovarian Cancer CAR-T Clinical Trial

Aug 25, 2023, 4:19 PM EDT - 1 year ago

Anixa Biosciences: Early Stage, Low Cash. Does It Matter?

Aug 14, 2023, 8:30 AM EDT - 1 year ago

Anixa Biosciences Announces Invited Presentation on Ovarian Cancer CAR-T Therapy at the 8th Annual CAR-TCR Summit

Aug 10, 2023, 9:30 AM EDT - 1 year ago

Could Anixa Biosciences (NASDAQ:ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer?

Aug 7, 2023, 8:30 AM EDT - 1 year ago

Anixa Biosciences Announces Opening of Enrollment for Keytruda® Arm in Ongoing Breast Cancer Vaccine Clinical Trial

MRK

Jul 27, 2023, 8:30 AM EDT - 1 year ago

Anixa Biosciences Announces Notice of Allowance of Additional Patent on Ovarian Cancer Vaccine Technology

Jul 11, 2023, 8:30 AM EDT - 1 year ago

Anixa Biosciences Announces Issuance of Canadian Patent for its CAR-T Cancer Therapy Technology

May 22, 2023, 8:30 AM EDT - 1 year ago

Anixa Biosciences Announces Treatment of Second Patient in its Ovarian Cancer CAR-T Clinical Trial

Apr 18, 2023, 7:13 PM EDT - 1 year ago

Anixa: I Am More Bullish After Efficacy Data For Its Triple-Negative Breast Cancer Vaccine

Apr 17, 2023, 3:27 PM EDT - 1 year ago

Anixa Biosciences Clarifies Poster Presentation on Company Website